[{"AccountsPayableCurrent_0_Q2_USD":26279.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_2_Q2_USD":-1036130.0,"OperatingIncomeLoss_1_Q2_USD":-770235.0,"NetInvestmentIncome_2_Q2_USD":36000.0,"NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_2_Q2_USD":-1004355.0,"NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_1_Q2_USD":-764601.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":-1004355.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-764601.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":null,"NetIncomeLoss_2_Q2_USD":-1004355.0,"NetIncomeLoss_1_Q2_USD":-764601.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-763660.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":32513.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":null,"LiabilitiesCurrent_0_Q2_USD":355208.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":null,"PreferredStockSharesIssued_0_Q2_shares":null,"PreferredStockSharesOutstanding_0_Q2_shares":null,"PreferredStockValue_0_Q2_USD":null,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":4702250.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":4702250.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":156357850.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q2_USD":-764601.0,"StockIssuedDuringPeriodSharesIssuedForServices_2_Q2_shares":25.0,"StockholdersEquity_0_Q2_USD":5000008.0,"SharePrice_0_Q2_USD":0.35,"SaleOfStockPricePerShare_0_Q2_USD":10.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1127401.0,"RestrictedInvestmentsPercentOfNetAssets_0_Q2_pure":0.2,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_2_Q2_USD":60000.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_1_Q2_USD":30000.0,"ProfitLoss_1_Q2_USD":-764601.0,"ProceedsFromSaleOfOtherInvestments_2_Q2_USD":32513.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":null,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":null,"PrepaidExpenseCurrent_0_Q2_USD":151355.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":167549316.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":16675000.0,"Liabilities_0_Q2_USD":6191458.0,"InterestIncomeOther_2_Q2_USD":32300.0,"CommonStockSharesHeldInEmployeeTrust_0_Q2_USD":4000.0,"CommonStockSharesAuthorized_0_Q2_shares":30000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockOtherSharesOutstanding_0_Q2_shares":21377250.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CashFDICInsuredAmount_0_Q2_USD":250000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-731147.0,"CommonStockSharesIssued_0_Q2_shares":5741465.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":582938.0,"BusinessCombinationConsiderationTransferred1_2_Q2_USD":1500000.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":166815023.0,"AssetsCurrent_0_Q2_USD":734293.0,"Assets_0_Q2_USD":167549316.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":6126835.0,"AccruedLiabilitiesCurrent_0_Q2_USD":292811.0,"AccruedIncomeTaxes_0_Q2_USD":526.0,"Cash_0_Q2_USD":600000.0,"CommonStockSharesOutstanding_0_Q2_shares":5741465.0,"CommonStockValue_0_Q2_USD":574.0,"DebtInstrumentConvertibleConversionPrice1_0_Q2_USD":10.0,"InterestIncomeOther_1_Q2_USD":5634.0,"InterestAndDividendIncomeSecuritiesOther_2_Q2_USD":32300.0,"InterestAndDividendIncomeSecuritiesOther_1_Q2_USD":5634.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-32141.0,"IncreaseDecreaseInAccruedTaxesPayable_2_Q2_USD":-6338.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":244163.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":null,"IncomeTaxExpenseBenefit_2_Q2_USD":525.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-1003830.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-764601.0,"GeneralAndAdministrativeExpense_2_Q2_USD":924644.0,"GeneralAndAdministrativeExpense_1_Q2_USD":712913.0,"FranchisorCosts_2_Q2_USD":3029.0,"EarningsPerShareDiluted_2_Q2_USD":-0.21,"EarningsPerShareDiluted_1_Q2_USD":-0.16,"EarningsPerShareBasicAndDiluted_2_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.0,"InvestmentIncomeInterest_2_Q2_USD":32300.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":16675000.0,"Ticker":"TNGX","CIK":"1819133","name":"BCTG ACQUISITION CORP.","OfficialName":"Tango Therapeutics Inc.","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"650767383.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]